Trials / Unknown
UnknownNCT02808013
Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS)
Prospective Randomized, Double-Blind, Placebo Controlled Study of NDS-446 (500 mg/Cap) in Men 45 Years of Age or Older With Moderate to Severe Lower Urinary Tract Symptoms (LUTS)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- Sponsor
- Naturex-Dbs · Industry
- Sex
- Male
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, Randomized, Double-Blind, Placebo Controlled clinical trial to study the efficacy and the safety of NDS-446 (500 mg/cap) in Men 45 years of age or older with moderate to severe lower urinary tract symptoms (LUTS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NDS-446 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-09-01
- First posted
- 2016-06-21
- Last updated
- 2016-06-21
Source: ClinicalTrials.gov record NCT02808013. Inclusion in this directory is not an endorsement.